Sphingosine kinase in cancer

被引：0
|
作者：
Pyne, Nigel J. [1 ,2 ]
Tonelli, Francesca [1 ,2 ]
Lim, Keng Gat [1 ,2 ]
Bittman, Robert [3 ]
Edwards, Joanne [4 ]
Watson, David G. [1 ,2 ]
Pyne, Susan [1 ,2 ]
机构：
[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Cell Biol Res Grp, Glasgow G4 0RE, Lanark, Scotland
[2] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Pharmaceut Anal & Metabol Res Grp, Glasgow G4 0RE, Lanark, Scotland
[3] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA
[4] Univ Glasgow, Inst Canc, Unit Expt Therapeut, Glasgow G11 6NT, Lanark, Scotland
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2012年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
115
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [31] Sphingosine Kinase 2 in Autoimmune/Inflammatory Disease and the Development of Sphingosine Kinase 2 Inhibitors
    Pyne, Nigel J.
    Adams, David R.
    Pyne, Susan
    TRENDS IN PHARMACOLOGICAL SCIENCES, 2017, 38 (07) : 581 - 591
  • [32] Sphingosine kinase: apoptosis regulating enzyme and chemotherapy target in prostate cancer
    Pshezhetskiy, Dmitry V.
    Doumerc, Nicolas
    Golzio, Muriel
    Malavaud, Bernard
    Kohama, Takafiami
    Cuvillier, Olivier
    FASEB JOURNAL, 2007, 21 (05) : A606 - A606
  • [33] Sphingosine kinase 1 as a potential therapeutic target in epithelial ovarian cancer
    Lee, Jeong-Won
    Ryu, Ji-Yoon
    Yoon, Gun
    Jeon, Hye-Kyung
    Cho, Young-Jae
    Choi, Jung-Joo
    Song, Sang Yong
    Do, In-Gu
    Lee, Yoo-Young
    Kim, Tae-Joong
    Choi, Chel Hun
    Kim, Byoung-Gie
    Bae, Duk-Soo
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (01) : 221 - 229
  • [34] INCREASED SPHINGOSINE KINASE-1 ACTIVITY AND EXPRESSION IN PROSTATE CANCER
    Malavaud, B.
    Pchejetski, D.
    Mazerolles, C.
    Silva, Russano De Paiva G.
    Calvet, C.
    Doumerc, D.
    Pitson, S.
    Rischmann, P.
    Cuvillier, O.
    EUROPEAN UROLOGY SUPPLEMENTS, 2010, 9 (02) : 277 - 277
  • [35] Overcoming enzalutamide resistance in metastatic prostate cancer by targeting sphingosine kinase
    Lin, Hui-Ming
    Mak, Blossom
    Yeung, Nicole
    Huynh, Kevin
    Meikle, Thomas G.
    Mellett, Natalie A.
    Kwan, Edmond M.
    Fettke, Heidi
    Tran, Ben
    Davis, Ian D.
    Mahon, Kate L.
    Zhang, Alison
    Stockler, Martin R.
    Briscoe, Karen
    Marx, Gavin
    Crumbaker, Megan
    Stricker, Phillip D.
    Du, Pan
    Yu, Jianjun
    Jia, Shidong
    Scheinberg, Tahlia
    Fitzpatrick, Michael
    Bonnitcha, Paul
    Sullivan, David R.
    Joshua, Anthony M.
    Azad, Arun A.
    Butler, Lisa M.
    Meikle, Peter J.
    Horvath, Lisa G.
    EBIOMEDICINE, 2021, 72
  • [36] Sphingosine Kinase 1 Is Overexpressed and Promotes Proliferation in Human Thyroid Cancer
    Guan, Hongyu
    Liu, Liehua
    Cai, Junchao
    Liu, Juan
    Ye, Caisheng
    Li, Mengfeng
    Li, Yanbing
    MOLECULAR ENDOCRINOLOGY, 2011, 25 (11) : 1858 - 1866
  • [37] Sphingosine Kinase 1 Isoform-Specific Interactions in Breast Cancer
    Yagoub, Daniel
    Wilkins, Marc R.
    Lay, Angelina J.
    Kaczorowski, Dominik C.
    Hatoum, Diana
    Bajan, Sarah
    Hutvagner, Gyorgy
    Lai, Jack H.
    Wu, Wengen
    Martiniello-Wilks, Rosetta
    Xia, Pu
    McGowan, Eileen M.
    MOLECULAR ENDOCRINOLOGY, 2014, 28 (11) : 1899 - 1915
  • [38] Sphingosine Kinase 1 and Cancer: A Systematic Review and Meta-Analysis
    Zhang, Yun
    Wang, Yan
    Wan, Zhi
    Liu, Shiping
    Cao, Yu
    Zeng, Zhi
    PLOS ONE, 2014, 9 (02):
  • [39] Prognostic Impact of Sphingosine Kinase 1 in Nonsmall Cell Lung Cancer
    Motono, Nozomu
    Ueda, Yoshimichi
    Shimasaki, Miyako
    Iwai, Shun
    Iijima, Yoshihito
    Usuda, Katsuo
    Uramoto, Hidetaka
    CLINICAL PATHOLOGY, 2021, 14
  • [40] Breast cancer sphingosine-1-phosphate is associated with phospho-sphingosine kinase 1 and lymphatic metastasis
    Tsuchida, Junko
    Nagahashi, Masayuki
    Nakajima, Masato
    Moro, Kazuki
    Tatsuda, Kumiko
    Ramanathan, Rajesh
    Takabe, Kazuaki
    Wakai, Toshifumi
    JOURNAL OF SURGICAL RESEARCH, 2016, 205 (01) : 85 - 94
12345